Press release from Companies: DanCann Pharma A/S: Notice of extraordinary general meeting

Press release from Companies: DanCann Pharma A/S intends to resolve on a partially (77 percent) guaranteed rights issue of approximately DKK 28.5 million

Press release from Companies: DanCann Pharma A/S publishes Q2-2022 report

Press release from Companies: DanCann Pharma A/S signs supply agreement with WEECO Pharma GmbH worth DKK 40 million

Press release from Companies: DanCann Pharma A/S: According to a recent opinion poll a majority of Danes are positive towards legalization of cannabis

Press release from Companies: DanCann Pharma A/S postpones quarterly report for Q2 2022

Press release from Companies: DanCann Pharma A/S: Standardized medicinal cannabis products are essential for the medical profession – and ultimately for the patients

Press release from Companies: DanCann Pharma A/S appoints Charlotte Hagedorn Jørgensen as new Head of Quality Assurance

Press release from Companies: DanCann Pharma A/S: CEO Jeppe Krog Rasmussen appointed to the board of The Danish Association of Listed Growth Companies

Press release from Companies: DanCann Pharma A/S: The acquisition of CannGros ApS shows a prominent EBITDA of DKK 1.6 million for the annual 2021-report

Press release from Companies: DanCann Pharma A/S has prolonged its loan facility of SEK 13.7 million

Press release from Companies: DanCann Pharma A/S publishes Q1-2022 report: Facing commercialization stage